170 related articles for article (PubMed ID: 1560187)
1. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
Miyamori I; Takeda Y; Takasaki H; Itoh Y; Iki K; Takeda R
J Endocrinol Invest; 1992 Jan; 15(1):19-24. PubMed ID: 1560187
[TBL] [Abstract][Full Text] [Related]
2. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.
Ulick S; Blumenfeld JD; Atlas SA; Wang JZ; Vaughan ED
J Clin Endocrinol Metab; 1993 Apr; 76(4):873-8. PubMed ID: 8473399
[TBL] [Abstract][Full Text] [Related]
3. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
4. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
5. Quantification of urinary 18-hydroxycortisol using LC-MS/MS.
Jin S; Wada N; Takahashi Y; Hui SP; Sakurai T; Fuda H; Takeda S; Fujikawa M; Yanagisawa K; Ikegawa S; Kurosawa T; Chiba H
Ann Clin Biochem; 2013 Sep; 50(Pt 5):450-6. PubMed ID: 23847032
[TBL] [Abstract][Full Text] [Related]
6. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
7. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Uchida K; Kigoshi T; Iwasaki R; Morimoto S
Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
[TBL] [Abstract][Full Text] [Related]
8. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
11. The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism.
Reynolds RM; Shakerdi LA; Sandhu K; Wallace AM; Wood PJ; Walker BR
Eur J Endocrinol; 2005 Jun; 152(6):903-7. PubMed ID: 15941931
[TBL] [Abstract][Full Text] [Related]
12. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Kater CE; Biglieri EG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
[TBL] [Abstract][Full Text] [Related]
13. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
16. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
[TBL] [Abstract][Full Text] [Related]
17. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.
Mulatero P; di Cella SM; Monticone S; Schiavone D; Manzo M; Mengozzi G; Rabbia F; Terzolo M; Gomez-Sanchez EP; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2012 Mar; 97(3):881-9. PubMed ID: 22238407
[TBL] [Abstract][Full Text] [Related]
18. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent.
Hamlet SM; Gordon RD; Gomez-Sanchez CE; Tunny TJ; Klemm SA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):317-22. PubMed ID: 2856057
[TBL] [Abstract][Full Text] [Related]
19. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives.
Mosso L; Gómez-Sánchez CE; Foecking MF; Fardella C
Hypertension; 2001 Sep; 38(3 Pt 2):688-91. PubMed ID: 11566957
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) based assay for the simultaneous quantification of 18-hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in human plasma.
Chen F; Cheng Z; Wang Z; Peng Y; Wang B; Guo W; Pan B
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123030. PubMed ID: 34871919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
